Ποια είναι η τιμή για Mizuho Medy Co.,Ltd. (4595)

Η τιμή για Mizuho Medy Co.,Ltd. (4595) είναι $11.27

Ποια είναι η κεφαλαιοποίηση αγοράς για Mizuho Medy Co.,Ltd. (4595)

Η κεφαλαιοποίηση αγοράς για Mizuho Medy Co.,Ltd. (4595) είναι $214.63M

Mizuho Medy Co.,Ltd. (4595) Τιμή και Κεφαλαιοποίηση Αγοράς

Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd. specializes in the research, development, production, and distribution of in-vitro diagnostic solutions, complemented by scientific and technical information services. While its primary operations are in Japan, the company maintains an international presence through import and export activities, extending its reach to countries including the United States, Belgium, Finland, the Netherlands, Taiwan, and Thailand. Its extensive product lineup includes a wide array of immunoassay test kits designed for detecting pathogens such as influenza viruses, RS virus, human metapneumovirus, Streptococcus pneumoniae, Legionella, Mycoplasma pneumoniae, adenovirus, rotavirus, norovirus, and Group A streptococcus. Additionally, Mizuho Medy offers kits for pregnancy, ovulation, and fecal occult blood screening. The company also provides advanced tools like gene analysis instruments and specialized diagnostic kits for SARS-CoV-2 detection and Mycoplasma pneumoniae nucleic acid analysis.

Η τιμή για 4595	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$284,760 $214.63M	NVDA	$5.424T	+2,527,148.83%
$250,721 $214.63M	AAPL	$4.776T	+2,225,048.29%
$212,709 $214.63M	GOOG	$4.052T	+1,887,692.87%
$193,769 $214.63M	MSFT	$3.691T	+1,719,603.17%
$144,065 $214.63M	AMZN	$2.744T	+1,278,478.97%

Η τιμή για 4595

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$284,760 $214.63M